GlassScriptPhysician profile
Thomas F Allred
NPI 1851343230
$372.69
in general payments reported to CMS, 2019-2025
10 companies · $45.68 in 2025
The $45.68 reported for 2025 was less than what a typical Neonatal-Perinatal Medicine provider received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.01 · 2022: $62.01 · 2023: $156 · 2024: $95.09 · 2025: $45.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $76.30 | 2023-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Cranial Technologies, INC | $63.13 | 2022-2023 | Doc Band |
| Sanofi Pasteur INC. | $48.93 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $41.35 | 2024-2025 | |
| Sobi, INC | $34.08 | 2020-2022 | |
| Glaxosmithkline, LLC. | $28.22 | 2022-2024 | Menveo, Rotarix, Bexsero |
| Genzyme Corporation | $24.55 | 2025 | |
| Nestle Healthcare Nutrition INC. | $24.06 | 2023 | |
| Supernus Pharmaceuticals, INC. | $18.76 | 2024 | Qelbree |
| Ironshore Pharmaceuticals INC. | $13.31 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.